WAVE Life Sciences (NASDAQ:WVE) Stock Quotes, Forecast and News Summary

Q: What sector and industry does WAVE Life Sciences (WVE) operate in?

WAVE Life Sciences is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

WAVE Life Sciences Stock (NASDAQ: WVE) stock price, news, charts, stock research, profile.

Open	$14.14
Close	$13.71
Volume / Avg.	1.57M / 1.63M
Day Range	$13.44 - $14.19
52 Wk Range	3.50 - 15.92
Market Cap	$2.17B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	69
Short Interest	5.55%
Days to Cover	5.07

Recent News

Oklo, CleanSpark And Wolfspeed Are Among Top 7 Mid Cap Gainers Last Week (Oct 14-18): Are The Others In Your Portfolio?

These seven mid-cap stocks were the best performers in the last week. Are they in your portfolio?

Lekha Gupta

This Cisco Analyst Turns Bullish; Here Are Top 5 Upgrades For Wednesday

Avi Kapoor

Wave Life Sciences Reveals RNA Editing Breakthrough, Reports First-Ever Clinical Proof-Of-Mechanism In Humans

Wave Life Sciences' WVE-006 demonstrates first-ever RNA editing in humans for alpha-1 antitrypsin deficiency, showing favorable safety and efficacy in early trial results. GSK holds global license rights with $525 million in milestone potential.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

May

Jun

Aug

Sep

Oct

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.7

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$14.14
Close	$13.71
Volume / Avg.	1.57M / 1.63M
Day Range	$13.44 - $14.19
52 Wk Range	3.50 - 15.92
Market Cap	$2.17B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	69
Short Interest	5.55%
Days to Cover	5.07

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy WAVE Life Sciences (WVE) stock?

You can purchase shares of WAVE Life Sciences (NASDAQ:WVE) through any online brokerage.

View our list of the best stock brokerages

Who are WAVE Life Sciences (WVE) competitors?

Other companies in WAVE Life Sciences’s space includes: Verona Pharma (NASDAQ:VRNA), Supernus Pharmaceuticals (NASDAQ:SUPN), Tarsus Pharmaceuticals (NASDAQ:TARS), Neumora Therapeutics (NASDAQ:NMRA) and Longboard Pharmaceuticals (NASDAQ:LBPH).

What is the forecast, or price target, for WAVE Life Sciences (WVE) stock?

WAVE Life Sciences has a consensus price target of $17.33.

What is the current price for WAVE Life Sciences (WVE)?

The stock price for WAVE Life Sciences (NASDAQ: WVE) is $14.2993 last updated October 31, 2024 at 5:43 PM EDT.

Does WAVE Life Sciences (WVE) pay a dividend?

There are no upcoming dividends for WAVE Life Sciences.

When is WAVE Life Sciences (NASDAQ:WVE) reporting earnings?

WAVE Life Sciences’s Q3 earnings are confirmed for Monday, November 11, 2024.

Is WAVE Life Sciences (WVE) going to split?

There is no upcoming split for WAVE Life Sciences.

What sector and industry does WAVE Life Sciences (WVE) operate in?

WAVE Life Sciences is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

Comments

WAVE Life Sciences

WAVE Life Sciences (WVE) Forecast